Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates

CONTEXT: Denosumab and zoledronic acid (ZOL) are parenteral treatments for patients with osteoporosis. OBJECTIVE: The objective of the study was to compare the effect of transitioning from oral bisphosphonates to denosumab or ZOL on bone mineral density (BMD) and bone turnover. DESIGN AND SETTING: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, P. D., Pannacciulli, N., Brown, J. P., Czerwinski, E., Nedergaard, B. S., Bolognese, M. A., Malouf, J., Bone, H. G., Reginster, J.-Y., Singer, A., Wang, C., Wagman, R. B., Cummings, S. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971333/
https://www.ncbi.nlm.nih.gov/pubmed/27270237
http://dx.doi.org/10.1210/jc.2016-1801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971333/
https://www.ncbi.nlm.nih.gov/pubmed/27270237
http://dx.doi.org/10.1210/jc.2016-1801

Ejemplares similares